Literature DB >> 27814610

Molecular mechanisms of the genetic risk factors in pathogenesis of Alzheimer disease.

Kunihiko Kanatsu1, Taisuke Tomita2.   

Abstract

Alzheimer disease (AD) is a neurodegenerative disease characterized by the extensive deposition of senile plaques and neurofibrillary tangles. Until recently, only the APOE gene had been known as a genetic risk factor for late-onset AD (LOAD), which accounts for more than 95% of all AD cases. However, in addition to this well-established genetic risk factor, genome-wide association studies have identified several single nucleotide polymorphisms as genetic risk factors of LOAD, such as PICALM and BIN1. In addition, whole genome sequencing and exome sequencing have identified rare variants associated with LOAD, including TREM2. We review the recent findings related to the molecular mechanisms by which these genetic risk factors contribute to AD, and our perspectives regarding the etiology of AD for the development of therapeutic agents.

Entities:  

Mesh:

Substances:

Year:  2017        PMID: 27814610     DOI: 10.2741/4480

Source DB:  PubMed          Journal:  Front Biosci (Landmark Ed)        ISSN: 2768-6698


  4 in total

1.  Targeting Infectious Agents as a Therapeutic Strategy in Alzheimer's Disease.

Authors:  Tamàs Fülöp; Usma Munawara; Anis Larbi; Mathieu Desroches; Serafim Rodrigues; Michele Catanzaro; Andrea Guidolin; Abdelouahed Khalil; François Bernier; Annelise E Barron; Katsuiku Hirokawa; Pascale B Beauregard; David Dumoulin; Jean-Philippe Bellenger; Jacek M Witkowski; Eric Frost
Journal:  CNS Drugs       Date:  2020-07       Impact factor: 6.497

2.  The Impact of EGFR Gene Polymorphisms on the Risk of Alzheimer's Disease in a Chinese Han Population: A Case-Controlled Study.

Authors:  Xiuhong Chen; Changhai Wang; Shuangbao Zhou; Xueyong Li; Lan Wu
Journal:  Med Sci Monit       Date:  2018-07-20

3.  HSPA1A, HSPA2, and HSPA8 Are Potential Molecular Biomarkers for Prognosis among HSP70 Family in Alzheimer's Disease.

Authors:  Yeqing Dong; Tongxin Li; Zhonghui Ma; Chi Zhou; Xinxu Wang; Jie Li
Journal:  Dis Markers       Date:  2022-09-30       Impact factor: 3.464

Review 4.  Recent Advancements in Pathogenesis, Diagnostics and Treatment of Alzheimer's Disease.

Authors:  Sahil Khan; Kalyani H Barve; Maushmi S Kumar
Journal:  Curr Neuropharmacol       Date:  2020       Impact factor: 7.363

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.